EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Phosphorous metabolism and manipulation in chronic kidney disease

Marco Marando, Adriana Tamburello, Davide Salera, Luca Di Lullo, Antonio Bellasi iD

Nephrology · 2024

DOI: 10.1111/nep.14407 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephrology, 2024. Verfasst von Marco Marando und 4 weiteren Autor:innen. Beteiligte Einrichtung: Service of Pneumology, Hôpitaux Universitaires de Genève, Geneva, Switzerland. Hauptthemen laut MEDLINE: Fibroblast Growth Factor-23, Phosphorus, Renal Insufficiency, Chronic, Chronic Kidney Disease-Mineral and Bone Disorder. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease‐mineral bone disorder (CKD‐MBD) is a syndrome commonly observed in subjects with impaired renal function. Phosphate metabolism has been implicated in the pathogenesis of CKD‐MBD and according to the phosphorocentric hypothesis may be the key player in the pathogenesis of these abnormalities. As phosphorous is an essential component for life, absorption from the bowel, accumulation and release from the bones, and elimination through the kidneys are all homeostatic mechanisms that maintain phosphate balance through very sophisticated feedback mechanisms, which comprise as main actors: vitamin D (VD), parathyroid hormone (PTH), calciproteins particles (CPPs), fibroblast growth factor‐23 (FGF‐23) and other phosphatonins and klotho. Indeed, as the renal function declines, factors such as FGF‐23 and PTH prevent phosphate accumulation and hyperphosphatemia. However, these factors per se may be responsible for the organ damages associated with CKD‐MBD, such as bone osteodystrophy and vascular calcification. We herein review the current understanding of the CKD‐MBD focusing on phosphorous metabolism and the impact of phosphate manipulation on surrogate and hard outcomes. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth Factor-23PhosphorusRenal Insufficiency, ChronicChronic Kidney Disease-Mineral and Bone DisorderHumansHyperphosphatemiaPhosphatesFibroblast Growth FactorsAnimalsKidney

Stichwörter der Autor:innen

CKDdialysisoutcomephosphate bindersphosphorous

Substanzen

Fibroblast Growth Factor-23PhosphorusFGF23 protein, humanPhosphatesFibroblast Growth Factors

Autor:innen und Institutionen

  • Service of Pneumology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Service of Nephrology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Department of Internal Medicine, Ospedale Regionale di Lugano, Ospedale Civico, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • UOC Nephrology and Dialysis Unit, Azienda USL Roma 6, Albano Laziale, Italy.
  • Service of Nephrology, Ospedale Regionale di Lugano, Ospedale Civico, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.

ORCID-Profile: Antonio Bellasi

Zitieren

APA

Marando, M., Tamburello, A., Salera, D., Di Lullo, L., & Bellasi, A. (2024). Phosphorous metabolism and manipulation in chronic kidney disease. Nephrology. https://doi.org/10.1111/nep.14407

Vancouver

Marando M, Tamburello A, Salera D, Di Lullo L, Bellasi A. Phosphorous metabolism and manipulation in chronic kidney disease. Nephrology. 2024. doi:10.1111/nep.14407

BibTeX
@article{Marando2024,
  author = {Marando, Marco and Tamburello, Adriana and Salera, Davide and Di Lullo, Luca and Bellasi, Antonio},
  title = {Phosphorous metabolism and manipulation in chronic kidney disease},
  journal = {Nephrology},
  year = {2024},
  doi = {10.1111/nep.14407}
}
Kostenlos starten →